UPMC’s Dr. Aatur Singhi Speaks on Early Diagnosis of Pancreatic Cysts

Watch an interview with the Director of UPMC Clinical Test Development Laboratory, Dr. Aatur Singhi, on Pittsburgh Today Live, as they discuss the importance of early testing and detection when fighting Pancreatic Cancer.

Genomic Test IDs Pancreatic Cysts Likely to Progress to Cancer Better Than Standard Guidelines

NEW YORK – In a prospective study of more than 1,800 patients at 31 clinical centers in the US, the PancreaSeq test developed at the University of Pittsburgh surpassed currently used guidelines for correctly classifying potentially cancerous pancreatic cysts.

Pitt-Developed Genetic Test for Pancreatic Cancer Outperforms Current Guidelines

PITTSBURGH —A molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, multi-center study led by University of Pittsburgh School of Medicine and UPMC researchers. 

Request Info